About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

COSMOS Pharmaceutical Corporation(3349) Financial Results

3349
TSE Prime
COSMOS Pharmaceutical Corporation
6,653
JPY
+247
(+3.86%)
Dec 23, 1:58 pm JST
42.48
USD
Dec 22, 11:58 pm EST
Result
PTS
outside of trading hours
6,648.1
Dec 23, 1:53 pm JST
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2021 726,424 33,147 35,835 27,156 342.9 35 Jul 12, 2021 J-GAAP
May, 2022 755,414 29,796 32,861 23,155 292.4 40 Jul 11, 2022 J-GAAP
May, 2023 827,697 30,128 33,086 23,797 300.5 50 Jul 10, 2023 J-GAAP
May, 2024 964,989 31,501 34,299 24,454 308.6 60 Jul 12, 2024 J-GAAP
May, 2025 Guidance 1,037,000 31,600 34,400 24,500 309.1 65 Jul 12, 2024 J-GAAP
YoY +7.5% +0.3% +0.3% +0.2% +0.2%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 964,989 33,147 35,835 27,156 342.9
Fiscal Year May, 2024 May, 2021 May, 2021 May, 2021 May, 2021
First Half
Result
Guidance History
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun - Nov, 2021 371,138 14,979 16,494 11,245 142.0 20 Jan 11, 2022 J-GAAP
Jun - Nov, 2022 404,016 15,385 16,900 11,299 142.7 21.25 Jan 13, 2023 J-GAAP
Jun - Nov, 2023 476,430 15,836 17,346 11,587 146.3 30 Jan 12, 2024 J-GAAP
Jun - Nov, 2024 Guidance 515,200 16,000 17,470 11,790 148.8 32.50 Jul 12, 2024 J-GAAP
YoY +8.1% +1.0% +0.7% +1.8% +1.7%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
May, 2022 29,796 -11,523 32,194 -43,717 -6,222 37,362 10.29 J-GAAP
May, 2023 30,128 5,321 54,434 -49,113 3,245 45,928 10.91 J-GAAP
May, 2024 31,501 -2,154 55,175 -57,329 8,527 52,301 10.98 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jun - Aug, 2022 206,122 8,900 9,626 6,481 81.8 57.0 Oct 11, 2022 J-GAAP
Jun - Aug, 2023 241,653 8,990 9,699 6,508 82.2 55.9 Oct 11, 2023 J-GAAP
Jun - Aug, 2024 261,841 11,580 12,293 8,143 102.7 70.4 Oct 11, 2024 J-GAAP
YoY +8.4% +28.8% +26.7% +25.1% +25.0%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Sep - Nov, 2022 197,894 6,485 7,274 4,818 60.8 3.3 Jan 13, 2023 J-GAAP
Dec - Feb, 2022 202,286 6,782 7,493 4,984 62.9 3.4 Apr 10, 2023 J-GAAP
Mar - May, 2023 221,395 7,961 8,693 7,514 94.9 3.6 Jul 10, 2023 J-GAAP
Jun - Aug, 2023 241,653 8,990 9,699 6,508 82.2 3.7 Oct 11, 2023 J-GAAP
Sep - Nov, 2023 234,777 6,846 7,647 5,079 64.1 2.9 Jan 12, 2024 J-GAAP
Dec - Feb, 2023 238,881 7,902 8,568 5,770 72.8 3.3 Apr 12, 2024 J-GAAP
Mar - May, 2024 249,678 7,763 8,385 7,097 89.6 3.1 Jul 12, 2024 J-GAAP
Jun - Aug, 2024 261,841 11,580 12,293 8,143 102.7 4.4 Oct 11, 2024 J-GAAP
YoY +8.4% +28.8% +26.7% +25.1% +25.0%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 261,841 11,580 12,293 8,509 107.4
Fiscal Year Aug, 2024 Aug, 2024 Aug, 2024 Feb, 2020 Feb, 2020
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
May, 2022 4,810.92 52.5 363,052 190,507 181,954 0.05 Jul 11, 2022 J-GAAP
May, 2023 5,330.26 50.1 420,967 211,072 202,485 0.09 Jul 10, 2023 J-GAAP
May, 2024 5,840.26 48.6 476,546 231,442 222,284 0.12 Jul 12, 2024 J-GAAP
Jun - Aug, 2024 48.9 485,031 237,204 228,050 0.11 Oct 11, 2024 J-GAAP